• Scouting, identifying and securing new business partnerships to contribute organic growth (License-Out, License-In, Distribution & Promotion, etc.) • Developing and managing partnering strategies and leading business transactions of multiple deals • Driving and implementing Alliance partners and ensuring business mandates and contractual obligations• People manager for BD1 team

• Double hats for SFE and Alliance (People manager for entire SFE/Training team)• Acting as a consultant and leveraging competitive industry /market information and recommending improvements that drive value and commercial effectiveness• Collaborating with Regional/Corp SFE team and local Sales leaderships(RSDs,FLM) to lead on the development of customer segmentation, territory allocation and sales performance & incentives.• Partnering with Senior Management team and proposing to ensure Sales Force organization structure's aligned with business strategy• Develop overall programs and ensuring execution of regular Training and Sales Incentive payouts

• Responsible BD&Alliance for Pharmaceuticals(Rx, OTC) and Consumer Health (directly reported to GM, first dedicated local BD/Alliance manager, people manager for assigned Marketer)• Identifying, exploring and setting up new business partnerships through finalizing deals with MNCs and local pharmas (5 new deals closed)• Specially focused on License-In opp. and Distribution deals in 4 TAs(Hemato-Onco, CV, URO, Rare/Orphan)• Developing strategic directions and new pipeline strategies for organization's growth priorities• Managing multiple deals with contractual obligations in Alliance & ensuring smooth business transitions and execution in line with Senior stakeholders (both Local and Regional)

• Double hats for both BD/Alliance and Marketing (People manager role included)• Contributed in setting up Commercial teams (Sales and Marketing/Women health team) in Korea • Led NPP and PAP for rare disease products for pre-launch activities • Developed strategies and executed marketing activities in specific TAs focusing on Ophthalmology, Pulmonology, Hemato-Oncology and Women’s Health • Engaged KOLs and Patient Advocacy Groups• Collaborated losely with HQ/Regional office for BD/NPD, License-In and Out, M&A deals• Full preparation of ‘Launch readiness’ for new product launch by engaging external/internal stakeholders

• Responsible projects as an NPD/BD manager: -Novo nordisk’s insulin portfolio (Targeted TA: Endocrinology) -Biocon’s insulin portfolio (“Glarzia®”- Lantus biosmilar, etc./ Targeted TA: Endocrinology) -New BD/NPD deals for co-promotion opp. with MNCs • Responsible products as a brand manager: - Atacand® (Targeted TA: Cardiovascular/Hypertension/AstraZeneca)- Lipidil Supra® & Cholib® (Targeted TA: Cardiovascular, Endocrinology/Dyslipidemia/Abbott)• Successfully negotiated key deal terms with existing partners (significant P&L contribution) • Contributed in signing out-partnering deals and managed multiple new NPD projects • Developed and pitched business proposals and capability decks to potential partner

• Responsible products (Anti-Infectives): - Zyvox® and Tygacil® (Targeted TA: Infectious Disease, Pulmonology, Critical Care) - Vfend® and Eraxis® (Targeted TA: Infectious Disease, Hematology, Critical Care)• Developed new business opportunities by capturing unmet medical needs and contributing in new indication and reimbursement guideline expansion• Executed Digital Marketing Initiative• Organized local CME programs with Global Marketing team to launch antibiotic stewardship • Built strong rapports with KOLs in Hematology, Infectious Disease and Pulmonology• Collaborated closely with Medical/RA/Market Access/PV/WS/Legal